However, these studies have been directed primarily at Axl- and MerTK-expressing cells within the tumor cell compartment, rather than in phagocytes of the tumor microenvironment, and clinical studies examining efferocytosis as an objective have not been reported. Here, MERTK is linked to neoplasm.